ICBMT 2025

Scientific Program

[SA03] Satellite Symposium 3 (GC Biopharma) September 13 (Sat), 08:30-09:00		Room C
Chair(s)	Jae-Ho Yoon (College of Medicine, The Catholic University of Korea, Korea)

08:30-09:00

Role of IVIG in Stem Cell Transplantation and Immunotherapy in Hematologic Disease

Dae-Ho Choi

Sungkyunkwan University School of Medicine, Korea

Abstract CV

[SA04] Satellite Symposium 4 (GlaxoSmithKline) September 13 (Sat), 08:30-09:00		Room D
Chair(s)	Chul Won Jung (Sungkyunkwan University School of Medicine, Korea)

08:30-09:00

Role of Momelotinib in the Treatment of Myelofibrosis with Anemia

Seo-Yeon Ahn

Chonnam National University Medical School, Korea

Abstract CV

[JS05] Joint Symposium 5 (ISCT-KSBMT): Bridging Cell Therapy and Hematopoietic Stem Cell Transplantation September 13 (Sat), 09:00-10:30		Room A
Chair(s)	Seok-Goo Cho (College of Medicine, The Catholic University of Korea, Korea) William Hwang (National Cancer Centre Singapore and Singapore General Hospital, Singapore)

09:00-09:30

Going Beyond Conventional CAR T Cell Therapies for Treatment of Blood Cancer and Other Diseases

William Hwang

National Cancer Centre Singapore and Singapore General Hospital, Singapore

Abstract CV
09:30-10:00

Virus-Specific T-Cell Therapy: The Ultimate Weapon in the Endless Battle Against Post-Transplant Viral Infections

Seok-Goo Cho

College of Medicine, The Catholic University of Korea, Korea

Abstract CV
10:00-10:30

Mesenchymal Stroma Cells (MSC) in Autoimmune Diseases: Clinical Application in Systemic Sclerosis and in Systemic Lupus Erythematosus

Dominique Farge

AP-HP, Saint-Louis Hospital, France

Abstract CV

[SS09] Scientific Session 9: Navigating Critical HSCT Complications September 13 (Sat), 09:00-10:30		Room C
Chair(s)	June-Won Cheong (Yonsei University College of Medicine, Korea) Hyo Jung Kim (Hallym University College of Medicine, Korea)

09:00-09:30

HokUS Scoring System for Predicting the Onset and Outcome of SOS

Souichi Shiratori

Hokkaido University Faculty of Medicine, Japan

Abstract CV
09:30-10:00

Diagnosis and Management of Transplant-Associated Thrombotic Microangiopathy (TA-TMA)

Sonata Jodele

Cincinnati Children’s Hospital Medical Center, USA

Abstract CV
10:00-10:30

Post-HSCT Viral Management: Strategies Beyond the Guidelines

Raeseok Lee

College of Medicine, The Catholic University of Korea, Korea

Abstract CV

[SS10] Scientific Session 10: Immunotherapy and Transplantation in Myeloid Malignancies: Evolving Strategies and Clinical Advances September 13 (Sat), 09:00-10:30		Room D
Chair(s)	Chul Won Jung (Sungkyunkwan University School of Medicine, Korea) Yoo Jin Kim (College of Medicine, The Catholic University of Korea, Korea)

09:00-09:30

Evolving Paradigms in AML: How Transplantation Fits in the Modern Therapeutic Landscape

Musa Yilmaz

The University of Texas MD Anderson Cancer Center, USA

Abstract CV
09:30-10:00

Immune Checkpoint Modulation in Myeloid Malignancies: Will We Find Success Soon?

Amer M. Zeidan

Yale Cancer Center, USA

Abstract CV
10:00-10:30

Augmenting NK-cell Immunity for the Treatment of Myeloid Malignancies using Hypomethylating Agents

Junshik Hong

Seoul National University College of Medicine, Korea

Abstract CV

[JS06] Joint Symposium 6 (TSBMT-KSBMT): Chronic GVHD or Rare Transplantation Related Complications September 13 (Sat), 10:40-11:40		Room A
Chair(s)	Jae-Ho Yoon (College of Medicine, The Catholic University of Korea, Korea) Hakan Goker (Hacettepe University Medical School, Türkiye)

10:40-11:10

Pathophysiology and Management of Chronic GVHD

Hakan Goker

Hacettepe University Medical School, Türkiye

Abstract CV
11:10-11:40

Neurologic Complications Following Hematopoietic Stem Cell Transplantation: Focus on Central Nervous System Graft-versus-Host Disease

Jin Kyung Suh

University of Ulsan College of Medicine, Korea

Abstract CV

[SS11] Scientific Session 11: Maximizing MM Treatment: Integrating Transplantation, Maintenance, and Novel Immunotherapies September 13 (Sat), 10:40-12:10		Room C
Chair(s)	Soo-Mee Bang (Seoul National University College of Medicine, Korea) Kihyun Kim (Sungkyunkwan University School of Medicine, Korea)

10:40-11:10

Do We Need ASCT for MM Patients in the New Agent Era?

Thierry Facon

Lille University Hospital, France

CV
11:10-11:40

Autologous NK Cell Therapy as a Consolidative Strategy after Auto-SCT

Evren Alici

Karolinska Institutet, Sweden

Abstract CV
11:40-12:10

The Role of Salvage Auto-HSCT in RRMM Patients

Jongheon Jung

National Cancer Center, Korea

Abstract CV

[NS02] Nursing Session 2: Multidisciplinary Approach to Treatment after Hematopoietic Stem Cell Transplantation ll (KOR.) September 13 (Sat), 10:40-11:40		Room D
Chair(s)	Heejun Kim (Samsung Medical Center, Korea)

10:40-11:10

How Can We Reduce Liver-Related Morbidity and Mortality in Patients after HSCT?

Pil Soo Sung

College of Medicine, The Catholic University of Korea, Korea

Abstract CV
11:10-11:40

Practical Oral Care for HSCT

Jusik Kim

Seoul National University College of Medicine, Korea

Abstract CV